SCHEMBL22646258

SCHEMBL22646258

COc1ccc(F)cc1-c1cc(C(=O)O)[nH]n1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALPL P05186 13/20 0.62
CA12 O43570 2/20 0.57
RPA1 P27694 1/20 0.57
CA9 Q16790 3/20 0.53
MAPT P10636 3/20 0.48
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
NPC1 O15118 1/20 0.48
USP2 O75604 1/20 0.48
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2D6 P10635 1/20 0.48
CYP2C9 P11712 1/20 0.48
ALOX15 P16050 1/20 0.48
MAPK1 P28482 1/20 0.48
CYP2C19 P33261 1/20 0.48
RAB9A P51151 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
TP53 P04637 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22415502 0.88 ALPL (0.72) ALPLMAPTMEN1KMT2ANPC1
SCHEMBL4198722 0.85 ALPL (0.71) ALPLCA12CA9MEN1KMT2A
SCHEMBL22415501 0.80 ALPL (0.63) ALPLCA12RPA1CA9MEN1
SCHEMBL4384447 0.78 ALPL (0.64) ALPLCA12RPA1CA9MAPT
SCHEMBL2056464 0.77 MEN1 (0.49) ALPLMAPTMEN1KMT2ANPC1
SCHEMBL13539286 0.77 ALPL (1.00) ALPLCA9MAPTMEN1KMT2A
SCHEMBL14152904 0.76 MAPT (0.77) ALPLCA12RPA1CA9MAPT
SCHEMBL3435547 0.76 ALPL (0.74) ALPLCA12CA9MAPTMEN1
SCHEMBL27951168 0.76 ALPL (0.59) ALPLCA12RPA1CA9TP53
SCHEMBL3447352 0.73 ALPL (1.00) ALPLCA12RPA1CA9TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11332461-B2 2-(1H-pyrazol-3-yl) phenol compound and use thereof BEIJING JIALIN PHARMACEUTICAL INC. (CN) 2022-05-17 US disclosed
US-20200354342-A1 2-(1H-PYRAZOL-3-YL) PHENOL COMPOUND AND USE THEREOF BEIJING JIALIN PHARMACEUTICAL INC. (CN) 2020-11-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11332461-B2 2-(1H-pyrazol-3-yl) phenol compound and use thereof VHL, PAH, TP53 ALPL 862/4885CA12 1481/4885RPA1 3155/4885
US-20200354342-A1 2-(1H-PYRAZOL-3-YL) PHENOL COMPOUND AND USE THEREOF VHL, PAH, TP53 ALPL 862/4885CA12 1481/4885RPA1 3155/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.